New hope for End-Stage breast cancer patients in major trial
Disease control
Recruiting now
This study is testing whether a new immunotherapy combination can help people with advanced metastatic breast cancer live longer when standard treatments have stopped working. The trial will compare the experimental treatment against whatever therapy a doctor would normally choos…
Phase: PHASE3 • Sponsor: BriaCell Therapeutics Corporation • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC